Trial Profile
A sorafenib treatment after radiological confirmation of disease progression in patients with advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Dec 2015 New trial record